Group Information: Investigators of the Emerging Risk Factors Collaboration include the following:
Atherosclerosis Risk in Communities Study: Wayne Rosamond, PhD; Eric Whitsel, PhD; and Mary Cushman, BSc (University of North
Carolina, Chapel Hill);
Australian Diabetes Study: Elizabeth L. M. Barr, PhD; Jonathan E. Shaw, MD; and Paul Z. Zimmet, MD (Baker Heart
and Diabetes Institute, Melbourne, Victoria, Australia);
Busselton Health Study: Matthew Knuiman, PhD (The University of Western Australia, Perth, Western Australia,
Australia);
British Regional Heart Study: Peter H. Whincup, PhD (St George’s, University of London, London, United Kingdom);
Bruneck Study: Stefan Kiechl, MD; Siegfried Weger, MD; and Johann Willeit, MD (Department of Internal
Medicine, Bruneck Hospital, Italy);
British Women’s Heart and Health Study: Deborah A. Lawlor, PhD (University of Bristol, Bristol, United Kingdom); Antoinette
Amuzu, MA; Caroline Dale, PhD; and Juan P. Casas, MD (University College London, London,
United Kingdom);
Caerphilly Prospective Study: John Gallacher, PhD (University of Oxford, Oxford, United Kingdom);
Cardiovascular Study in the Elderly: Valérie Tikhonoff, MD (University of Padua, Padua, Italy);
Chicago Heart Association Detection Project In Industry: Philip Greenland, MD (Northwestern University, Chicago, Illinois);
Charleston Heart Study: Paul Nietert, PhD (Medical University of South Carolina, Charleston);
Copenhagen City Heart Study: Anne Tybjærg-Hansen, MD; Ruth Frikke-Schmidt, MD; and Gorm B. Jensen, MD (University
of Copenhagen, Copenhagen, Denmark);
Diet and Risk of Cardiovascular Disease in Spain: David Lora Pablos, MD; and Pilar Cancelas Navia, MD (Hospital 12 de Octubre, Madrid,
Spain);
Dubbo Study of the Elderly: Leon Simons, MD (University of New South Wales, Sydney, New South Wales, Australia);
Edinburgh Artery Study: Stela McLachlan, PhD (The University of Edinburgh, Edinburgh, United Kingdom);
Epidemiologische Studie zu Chancen der Verhutung und optimierten Therapie chronischer
Erkrankungen in der alteren Bevolkerung:
Ben Schöttker, MD; Kai-Uwe Saum, PhD; and Bernd Holleczek, PhD (German Cancer Research
Center, Heidelberg, Germany);
Oslo Study, Cohort of Norway: Inger Ariansen, PhD; Haakon E. Meyer, MD; and Lise Lund Håheim, MD (Norwegian Institute
of Public Health, Oslo, Norway);
Finrisk Cohort 1992, Finrisk Cohort 1997: Erkki Vartiainen, MD; Pekka Jousilahti, MD; and Kennet Harald, MD (National Institute
for Health and Welfare, Helsinki, Finland);
The Glucose Intolerance, Obesity and Hypertension Study: Rachel Dankner, MD (Tel Aviv University, Tel Aviv, Israel);
Goteborg Study 1933, MONICA Göteborg Study: Annika Rosengren, MD; and Lars Wilhelmsen, MD (University of Gothenburg, Gothenburg,
Sweden);
Population Study of Women in Göteborg, Sweden: Cecilia Björkelund, MD (University of Gothenburg, Gothenburg, Sweden);
Göttingen Risk Incidence and Prevalence Study: Dorothea Nagel, MD (German Cancer Research Center, Heidelberg, Germany);
Hertfordshire Cohort Study: Elaine Dennison, PhD; Holly Syddall, PhD; and Leo Westbury, MSc (University of Southampton,
Southampton, United Kingdom);
Health in Men Study: Leon Flicker, PhD; Graeme J. Hankey, MD (University of Western Australia, Perth,
Western Australia, Australia); and Jonathan Golledge, MD (James Cook University, Townsville,
Queensland, Australia);
Hisayama Study: Toshiharu Ninomiya, PhD; Yasufumi Doi, PhD; and Yutaka Kiyohara, PhD (Kyushu University,
Fukuoka, Japan);
Honolulu Heart Program: Beatriz Rodriguez, MD (University of Hawaii, Honolulu);
Hoorn Study: Petra Elders, MD; and Coen Stehouwer, MD (VU University Medical Center, Amsterdam,
the Netherlands);
Health Professionals Follow-up Study: Christopher Kabrhel, MD (Massachusetts General Hospital, Boston); and Majken Jensen,
PhD (Harvard T. H. Chan School of Public Health, Boston, Massachusetts);
Ikawa, Kyowa, and Noichi Study: Akihiko Kitamura, MD (Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan);
Hiroyasu Iso, MD (Osaka University Graduate School of Medicine, Suita, Japan); and
Kazumasa Yamagishi, MD (University of Tsukuba, Tsukuba, Japan);
North Karelia Project: Veikko Salomaa, MD (National Institute for Health and Welfare, Helsinki, Finland);
Kuopio Ischaemic Heart Disease Study: Kurl Sudhir, MD; Tomi-Pekka Tuomainen, PhD; and Jukka T. Salonen, MD (University
of Eastern Finland, Keupio, Finland);
Lower Extremity Arterial Disease Event Reduction Trial, Northwick Park Heart Study
II:
Jackie A. Cooper, MBBS, (UCL Medical School, University College London, London, United
Kingdom);
Monitoring of CVD Risk Factors Project, Dutch Monitoring Project on Risk Factors for
Chronic Diseases:
Jolanda M. A. Boer, PhD; and Anneke Blokstra, PhD (National Institute for Public
Health and the Environment [RIVM], Bilthoven, the Netherlands);
Malmö Diert and Cancer Cardiovascular Study, Malmö Preventive Project: Olle Melander, MD; Peter M. Nilsson, MD; and Gunnar Engström, PhD (Lund University,
Lund, Sweden);
Risk Factors and Life Expectancy Pooling Project, Risk Factors and Life Expectancy
Pooling Project:
Maurizio Trevisan, MD (The City College of New York, New York);
Progetto CUORE: Luigi Palmieri, MD; Diego Vanuzzo, MD; and Simona Giampaoli, MD (National Health
Institute of Health [ISS], Rome, Italy);
MONICA/KORA Augsburg Survey S1, MONICA/KORA Augsburg Survey S2, MONICA/KORA Augsburg
Survey S3:
Annette Peters, MD; Barbara Thorand, PhD; and Margit Heier, PhD (German Research
Center for Environmental Health, Neuherberg, Germany);
MRC Study of Older People: Astrid Fletcher, MD (London School of Hygiene and Tropical Medicine, London, United
Kingdom);
Multiple Risk Factor Intervention Trial 1: Lewis H. Kuller, PhD (University of Pittsburgh Graduate School of Public Health,
Pittsburgh, Pennsylvania);
National Health and Nutrition Examination Survey I: Juan R. Albertorio-Diaz, MA (US Centers for Disease Control and Prevention, Atlanta,
Georgia);
Nurses’ Health Study: Eric B. Rimm, ScD; Frank B. Hu, MD; and JoAnn E. Manson, MD (Harvard T. H. Chan School
of Public Health, Boston, Massachusetts);
Prevention of Renal and Vascular End Stage Disease Study: Karina Meijer, MD; Ron T. Gansevoort, MD (University of Groningen, Groningen, the
Netherlands);
Puerto Rico Heart Health Program: Carlos J. Crespo, MD (Portland State University, Portland, Oregon);
Prospective Cardiovascular Münster Study: Gerd Assmann, MD (Assmann Foundation for Prevention, Münster, Germany); and Helmut
Schulte, PhD (University of Münster, Münster, Germany);
Prospect EPIC Utrecht: Ivonne Sluijs, PhD (University Medical Center Utrecht, Utrecht, the Netherlands);
Quebec Cardiovascular Study: Bernard Cantin, PhD; Benoît Lamarche, PhD; and Gilles R. Dagenais, MD (Université
Laval, Quebec, Quebec, Canada);
Rancho Bernardo Study: Linda McEvoy, PhD; Gail Laughlin, PhD; and Lori B. Daniels, MD (University of California,
San Diego);
Reykjavik Study: Thor Aspelund, PhD; Elías Freyr Gudmundsson, PhD; and Bolli Thorsson, PhD (University
of Iceland, Reykjavík, Iceland);
The Rotterdam Study: Maarten J. G. Leening, PhD; M. Arfan Ikram, MD; and Oscar H. Franco, MD (Erasmus
Medical Centre, Rotterdam, the Netherlands);
Scottish Heart Health Extended Cohort: Hugh Tunstall-Pedoe, MD (Dundee University, Dundee, United Kingdom);
Study of Health in Pomerani: Henry Völzke, MD; and André Werner, MD (University of Greifswald, Greifswald, Germany);
Strong Heart Study: Richard Devereux, MD (Weill Cornell Medicine, New York, New York); and Stacey Jolly,
MD (Cleveland Clinic, Phoenix, Arizona);
Speedwell Study: George Davey Smith, MD (Bristol University, Bristol, United Kingdom);
Turkish Adult Risk Factor Study: Günay Can, MD (Trakya University, Edime, Turkey); Hüsniye Yüksel, MD (Ataşehir Florence
Nightingale Hospital, Istanbul, Turkey); and Servet Altay, MD (Trakya University,
Edime, Turkey);
Tromsø Study: Inger Njølstad, MD (The Arctic University of Norway, Tromsø, Norway);
Uppsala Longitudinal Study of Adult Men: Martin Ingelsson, MD; and Vilmantas Giedraitis, PhD (Uppsala University, Uppsala,
Sweden);
Wuertemberg Construction Workers Cohort: Hermann Brenner, MD (German Cancer Research Center, Heidelberg, Germany); Heiner
Claessen, PhD (German Diabetes Center, Düsseldorf, Germany); and Dietrich Rothenbacher,
MD (University of Ulm, Ulm, Germany);
Women’s Health Initiative: Nisha I. Parikh, MD (University of California, San Francisco); and Charles Eaton,
MD (Care New England, Pawtucket, Rhode Island);
Whitehall I Study: Martin Shipley, MSc; and Mika Kivimaki, FMedSci (University College London, London,
United Kingdom);
Whitehall II Study: Eric J. Brunner, PhD; and Martin Shipley, MSc (University College London, London,
United Kingdom); and
Zutphen Elderly Study: Edith Feskens, MD; Johanna M. Geleijnse, MD; and Daan Kromhout, MD (Wageningen University,
Wageningen, the Netherlands); Data Management Team: Thomas Bolton, MSc; Sarah Spackman,
MMath; and Matthew Walker, PhD (MRC/BHF Cardiovascular Epidemiology Unit, Department
of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom).
Coordinating Centre: Thomas Bolton, MSc; Stephen Burgess, PhD; Adam S. Butterworth,
PhD; Emanuele Di Angelantonio, FRCP; Stephen Kaptoge, PhD; Lisa Pennells, PhD; Sarah
Spackman, MMath; Simon G. Thompson, PhD; Matthew Walker, PhD; Angela M. Wood, PhD;
and John Danesh, FMedSci (principal investigator) (MRC/BHF Cardiovascular Epidemiology
Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge,
United Kingdom).
